Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial

The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment. Accurate prediction of SB occlusion after main vessel stenting followed by the use of sp...

Full description

Saved in:
Bibliographic Details
Published inJACC. Cardiovascular interventions Vol. 13; no. 9; p. 1112
Main Authors Dou, Kefei, Zhang, Dong, Pan, Hongwei, Guo, Ning, Li, Lang, Li, Yue, Zhang, Qi, Liu, Bin, Shen, Zhujun, Zhang, Bin, Liu, Jian, Han, Wei, Wang, Yang, Zhao, Yanyan, Yang, Yuejin, Chen, Shaoliang, Xie, Lihua, Guan, Changdong, Kirtane, Ajay J, Xu, Bo
Format Journal Article
LanguageEnglish
Published United States 11.05.2020
Subjects
Online AccessGet full text
ISSN1876-7605
1876-7605
DOI10.1016/j.jcin.2020.01.233

Cover

Abstract The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment. Accurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention. Eligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall. A total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01). An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434).
AbstractList The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment. Accurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention. Eligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall. A total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01). An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434).
The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment.OBJECTIVESThe aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment.Accurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention.BACKGROUNDAccurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention.Eligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall.METHODSEligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall.A total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01).RESULTSA total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01).An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434).CONCLUSIONSAn active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434).
Author Kirtane, Ajay J
Zhang, Dong
Zhang, Qi
Chen, Shaoliang
Pan, Hongwei
Dou, Kefei
Yang, Yuejin
Shen, Zhujun
Han, Wei
Wang, Yang
Liu, Bin
Zhao, Yanyan
Xu, Bo
Guan, Changdong
Liu, Jian
Li, Yue
Zhang, Bin
Xie, Lihua
Guo, Ning
Li, Lang
Author_xml – sequence: 1
  givenname: Kefei
  surname: Dou
  fullname: Dou, Kefei
  email: drdoukefei@126.com
  organization: State Key Laboratory of Cardiovascular Disease, Beijing, China; Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China. Electronic address: drdoukefei@126.com
– sequence: 2
  givenname: Dong
  surname: Zhang
  fullname: Zhang, Dong
  organization: State Key Laboratory of Cardiovascular Disease, Beijing, China; Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China
– sequence: 3
  givenname: Hongwei
  surname: Pan
  fullname: Pan, Hongwei
  organization: Department of Cardiology, Hunan Provincial People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha, China
– sequence: 4
  givenname: Ning
  surname: Guo
  fullname: Guo, Ning
  organization: Department of Cardiology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
– sequence: 5
  givenname: Lang
  surname: Li
  fullname: Li, Lang
  organization: Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
– sequence: 6
  givenname: Yue
  surname: Li
  fullname: Li, Yue
  organization: Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, Harbin, China
– sequence: 7
  givenname: Qi
  surname: Zhang
  fullname: Zhang, Qi
  organization: Department of Cardiology, Shanghai East Hospital, Tongji University, Shanghai, China
– sequence: 8
  givenname: Bin
  surname: Liu
  fullname: Liu, Bin
  organization: Department of Cardiology, the Second Hospital of Jilin University, Changchun, China
– sequence: 9
  givenname: Zhujun
  surname: Shen
  fullname: Shen, Zhujun
  organization: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 10
  givenname: Bin
  surname: Zhang
  fullname: Zhang, Bin
  organization: Department of Cardiology, Guangdong General Hospital, Guangzhou, China
– sequence: 11
  givenname: Jian
  surname: Liu
  fullname: Liu, Jian
  organization: Departments of Cardiology, Peking University People's Hospital, Beijing, China
– sequence: 12
  givenname: Wei
  surname: Han
  fullname: Han, Wei
  organization: Department of Cardiology, the Third Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, China
– sequence: 13
  givenname: Yang
  surname: Wang
  fullname: Wang, Yang
  organization: Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China
– sequence: 14
  givenname: Yanyan
  surname: Zhao
  fullname: Zhao, Yanyan
  organization: Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China
– sequence: 15
  givenname: Yuejin
  surname: Yang
  fullname: Yang, Yuejin
  organization: State Key Laboratory of Cardiovascular Disease, Beijing, China; Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China
– sequence: 16
  givenname: Shaoliang
  surname: Chen
  fullname: Chen, Shaoliang
  organization: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
– sequence: 17
  givenname: Lihua
  surname: Xie
  fullname: Xie, Lihua
  organization: Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 18
  givenname: Changdong
  surname: Guan
  fullname: Guan, Changdong
  organization: Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 19
  givenname: Ajay J
  surname: Kirtane
  fullname: Kirtane, Ajay J
  organization: Center for Interventional Vascular Therapy, Columbia University Medical Center/NewYork-Presbyterian Hospital, and the Cardiovascular Research Foundation, New York, New York
– sequence: 20
  givenname: Bo
  surname: Xu
  fullname: Xu, Bo
  email: bxu@citmd.com
  organization: National Clinical Research Center for Cardiovascular Diseases, Beijing, China; Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: bxu@citmd.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32381188$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1OwkAcxDcGIx_6Ah7MHr20_ne3n96AoJCQQKBybbbLv7LYdmu3kPg2PotPJkZMPM0k88tkMn3SqUyFhNwycBmw4GHv7pWuXA4cXGAuF-KC9FgUBk4YgN_557ukb-0eIIA45FekK7iIGIuiHimHqtVHpOuRs6QbbOzB0rGpjli12lSyoMO6boxUO9oa2u6QLhvTovoJqcnpVL_unJW2b1-fa71FOmpkpXZoH2lyYsezxFlN1ov5ZkKTRsvimlzmsrB4c9YBeXmaJOOpM188z8bDuVNzxlpHZRxy34tRxSHmkCnJRZ5JEWc5-iEGSniCxQByC56f576KA7b1wxAEQ-F7KAbk_rf3tP39gLZNS20VFoWs0Bxsyj0AX4TCi07o3Rk9ZCVu07rRpWw-0r-LxDf3Bmra
ContentType Journal Article
Copyright Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
CorporateAuthor CIT-RESOLVE Investigators
CorporateAuthor_xml – name: CIT-RESOLVE Investigators
DBID NPM
7X8
DOI 10.1016/j.jcin.2020.01.233
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1876-7605
ExternalDocumentID 32381188
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
0SF
18M
1B1
1P~
1~.
4.4
457
4G.
53G
5GY
5VS
7-5
8P~
AACTN
AAEDW
AAFTH
AAIKJ
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABVKL
ACGFO
ACGFS
ADBBV
ADEZE
ADVLN
AEFWE
AEKER
AEVXI
AEXQZ
AFCTW
AFETI
AFJKZ
AFRHN
AFTJW
AGYEJ
AITUG
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
BAWUL
BLXMC
CS3
DIK
EBS
F5P
FDB
FEDTE
FNPLU
GBLVA
HVGLF
IXB
J1W
M41
MO0
N9A
NPM
O-L
O9-
OAUVE
OA~
OK1
OL0
P-8
P-9
P2P
PC.
Q38
ROL
SDF
SEL
SES
SSZ
T5K
W8F
Z5R
7X8
AAYWO
EFKBS
EFLBG
~HD
ID FETCH-LOGICAL-p211t-cb20f549ec97ef0bca23fba39bfe57e6c3431900ad045ff5c961d577031e354e3
ISSN 1876-7605
IngestDate Sat Sep 27 22:30:44 EDT 2025
Wed Feb 19 02:30:07 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords coronary bifurcation intervention
conventional strategy
active side branch protection strategy
side branch occlusion
randomized controlled trial
Language English
License Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p211t-cb20f549ec97ef0bca23fba39bfe57e6c3431900ad045ff5c961d577031e354e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 32381188
PQID 2400537348
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2400537348
pubmed_primary_32381188
PublicationCentury 2000
PublicationDate 2020-May-11
20200511
PublicationDateYYYYMMDD 2020-05-11
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-May-11
  day: 11
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JACC. Cardiovascular interventions
PublicationTitleAlternate JACC Cardiovasc Interv
PublicationYear 2020
SSID ssj0060972
Score 2.4139605
Snippet The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1112
Title Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial
URI https://www.ncbi.nlm.nih.gov/pubmed/32381188
https://www.proquest.com/docview/2400537348
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1876-7605
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060972
  issn: 1876-7605
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect
  customDbUrl:
  eissn: 1876-7605
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0060972
  issn: 1876-7605
  databaseCode: IXB
  dateStart: 20080201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection 2013
  customDbUrl:
  eissn: 1876-7605
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060972
  issn: 1876-7605
  databaseCode: .~1
  dateStart: 20080201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1876-7605
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0060972
  issn: 1876-7605
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiPcuLxkJcalcJXGc1Ny6pUsXdR9iU9RbFCe26Ao1BRohceGvMxM7mxSKtHCJKstt08zX8Ty-mSHklYy5HBo_ZCr2wUHxuWJZEWUshuPGN0qoPMN4x8lpNJ2H7xdi0ev97LCWqo0a5D921pX8j1RhDeSKVbL_INmrD4UFeA3yhStIGK7XkvGoVlb9i0N23sfAV1UP4GxZ5KN1WzCFBua5bcrgbESkeLAPSC2_WBbIEgAAfLIUuXqa3XHCQDxns4-TfoI_ZsuOHY3HA2SLbJFZO_zJdl59Wdn6H6OXf0Sp35bu4KyTWLUCnMLS93bru6q0gHUbXYAiqHPrToFanQoKl8WRZ5PXesdao4h5B3Cyo1VBHwc71b2NPFwOLvMl9rINPGzBGtjOGtu9tU_P0qP5bJYmk0Xyev2F4dgxTM-7GSw3yM0gjiIcgXG8OGyO8gh7G6HH3tytq7qyBMHfv_TvPkptqyR3yR3nZNCRRcw90tOr--TWiaNRPCCfLXAoAoda4NAucGgDHLopKQCHtsChpaFXwKEIHNoA5w0F2NAObGgNm4dkfjRJxlPmxm6wdeD7G5arwDMilDqXsTYe_FsDblTGpTJaxDrKORid0vOyAtwBY0QuI78QMQ5C0FyEmj8ie6typfcJ5eiNS6lFYbLQcDgc_DguYE8kMqm4PiAvm0eWglrDXFW20mX1LUVqs-DYeumAPLbPMl3b_ispRzPTHw6fXOPdT8ntFpPPyN7ma6Wfgxm5US9qUf8CEKRxLA
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Active+SB-P+Versus+Conventional+Approach+to+the+Protection+of+High-Risk+Side+Branches%3A+The+CIT-RESOLVE+Trial&rft.jtitle=JACC.+Cardiovascular+interventions&rft.au=Dou%2C+Kefei&rft.au=Zhang%2C+Dong&rft.au=Pan%2C+Hongwei&rft.au=Guo%2C+Ning&rft.date=2020-05-11&rft.issn=1876-7605&rft.eissn=1876-7605&rft.volume=13&rft.issue=9&rft.spage=1112&rft_id=info:doi/10.1016%2Fj.jcin.2020.01.233&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1876-7605&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1876-7605&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1876-7605&client=summon